Volpara Health Technologies Limited Stock OTC Markets

Equities

VPAHF

NZVHTE0001S6

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 03:21:56 2024-05-01 pm EDT 5-day change 1st Jan Change
0.74 USD +36.63% Intraday chart for Volpara Health Technologies Limited 0.00% +32.28%
Sales 2024 39.14M 26.03M Sales 2025 * 50.92M 33.87M Capitalization 291M 194M
Net income 2024 -8M -5.32M Net income 2025 * -3M -2M EV / Sales 2024 7.38 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 5.72 x
P/E ratio 2024 *
-45.6 x
P/E ratio 2025 *
-76.9 x
Employees 156
Yield 2024 *
-
Yield 2025 *
-
Free-Float 74.97%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Volpara Health Technologies Limited

1 day+36.63%
Current month+36.63%
1 month+24.89%
3 months+5.71%
6 months+53.81%
Current year+32.28%
More quotes
1 month
0.74
Extreme 0.74
0.74
Current year
0.54
Extreme 0.5416
0.89
1 year
0.41
Extreme 0.41
0.89
3 years
0.28
Extreme 0.281
1.01
5 years
0.28
Extreme 0.281
1.42
10 years
0.28
Extreme 0.281
1.42
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-04-19
Founder - 08-12-31
Director of Finance/CFO - 16-06-30
Members of the board TitleAgeSince
Founder - 08-12-31
Chief Executive Officer - 22-04-19
More insiders
Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings